Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024
Karen B. Jacobson, Andrew Watson, Maqdooda Merchant, Bruce Fireman, Ousseny Zerbo, Nicola P. Klein
Abstract
This cohort study examines uptake of maternal respiratory syncytial virus (RSV) vaccination and infant receipt of nirsevimab during the early period of availability for these medications.
Topics & Concepts
ReceiptVaccinationMedicineCohortPediatricsVirusVirologyInternal medicineWorld Wide WebComputer scienceRespiratory viral infections researchPneumonia and Respiratory InfectionsNeonatal Respiratory Health Research